Lewis B. Silverman, MD

Clinical Director, Pediatric Hematologic Malignancies Center
Medical Director, Inpatient Oncology
Institute Physician
Associate Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-6191
Appointment Phone: 888-733-4662 (new); 617-632-3270 (established)
Fax: 617-632-5710
Preferred Contact Method: email


Treatment Centers
Pediatric Hematology/Oncology
Clinical Interests
Acute lymphoblastic leukemia (ALL)


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215


Board Certifications
Pediatric Hematology/Oncology, 1998
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 1996
Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics, 07/92 to 06/94
Children's Hospital Boston, 07/91 to 06/92
Medical School
Harvard Medical School, 1991
Dr. Silverman received his MD from Harvard Medical School in 1991 and training in pediatrics at Children's Hospital Boston in 1994. He subsequently completed a fellowship in pediatric hematology-oncology at Children's Hospital and DFCI. In 1997, he became an attending physician in pediatric oncology at Children's Hospital and DFCI, where he currently is medical director of the Inpatient Oncology Serive and chief of the Pediatric Hematologic Malignancy Service. He is the principal investigator of the DFCI ALL Consortium, a multi-institutional group conducting clinical trials in children with newly diagnosed and relapsed ALL.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.